Outcome of 561 non-metastatic triple negative breast cancer patients: Multi-center experience from Turkey


Budakoglu B., Altundag K., Aksoy S., Kaplan M. A., Ozdemir N. Y., Berk V., ...Daha Fazla

JOURNAL OF BUON, cilt.19, sa.4, ss.872-878, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 4
  • Basım Tarihi: 2014
  • Dergi Adı: JOURNAL OF BUON
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.872-878
  • Anahtar Kelimeler: breast cancer, prognosis, treatment, triple negative, CHEMOTHERAPY, SUBTYPES, RECURRENCE, PATTERNS, TUMORS, TRIAL
  • Gazi Üniversitesi Adresli: Evet

Özet

Purpose: Triple-negative breast cancers account for 15% of breast carcinomas and, when present as early-stage disease, they are associated with higher rates of recurrence and early distant metastasis risk when compared to hormone receptor positive and human epidermal growth factor receptor (HER-2) positive breast cancers. In this study we aimed to explore the basic clinicopathological characteristics, prognostic factors and recurrence patterns of non-metastatic triple negative breast cancer patients.